A detailed history of Vontobel Holding Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Vontobel Holding Ltd. holds 6,283,743 shares of ABT stock, worth $804 Million. This represents 2.61% of its overall portfolio holdings.

Number of Shares
6,283,743
Previous 6,473,097 2.93%
Holding current value
$804 Million
Previous $738 Million 3.69%
% of portfolio
2.61%
Previous 2.53%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

SELL
$111.93 - $119.39 $21.2 Million - $22.6 Million
-189,354 Reduced 2.93%
6,283,743 $711 Million
Q3 2024

Oct 15, 2024

SELL
$100.07 - $118.13 $997,998 - $1.18 Million
-9,973 Reduced 0.15%
6,473,097 $738 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $611 Million - $683 Million
6,070,200 Added 1470.24%
6,483,070 $674 Million
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $38.7 Million - $42.7 Million
-353,241 Reduced 46.11%
412,870 $46.9 Million
Q4 2023

Jun 03, 2024

SELL
$90.19 - $110.4 $5.25 Million - $6.42 Million
-58,158 Reduced 12.12%
421,823 $46.4 Million
Q4 2023

Jan 29, 2024

SELL
$90.19 - $110.4 $3.54 Million - $4.34 Million
-39,270 Reduced 4.88%
766,111 $84.3 Million
Q3 2023

Jun 03, 2024

BUY
$95.53 - $114.62 $8.92 Million - $10.7 Million
93,400 Added 24.16%
479,981 $46.5 Million
Q3 2023

Oct 10, 2023

BUY
$95.53 - $114.62 $10.5 Million - $12.5 Million
109,438 Added 15.73%
805,381 $78 Million
Q2 2023

Jun 03, 2024

BUY
$100.78 - $112.29 $1.53 Million - $1.7 Million
15,175 Added 4.09%
386,581 $42.1 Million
Q2 2023

Jul 24, 2023

BUY
$100.78 - $112.29 $3.39 Million - $3.77 Million
33,589 Added 5.07%
695,943 $75.9 Million
Q1 2023

Jun 03, 2024

SELL
$96.86 - $114.01 $4.02 Million - $4.73 Million
-41,464 Reduced 10.04%
371,406 $37.6 Million
Q1 2023

Apr 12, 2023

BUY
$96.86 - $114.01 $26.6 Million - $31.3 Million
274,658 Added 70.84%
662,354 $67.1 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $1.23 Million - $1.45 Million
12,979 Added 3.46%
387,696 $42.6 Million
Q3 2022

Nov 04, 2022

BUY
$96.76 - $112.03 $7.5 Million - $8.68 Million
77,494 Added 26.07%
374,717 $36.3 Million
Q2 2022

Jul 27, 2022

SELL
$102.07 - $123.37 $2.88 Million - $3.48 Million
-28,232 Reduced 8.67%
297,223 $32.4 Million
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $4.63 Million - $5.64 Million
-40,586 Reduced 11.09%
325,455 $39.2 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $5.08 Million - $6.22 Million
43,961 Added 13.65%
366,041 $51.6 Million
Q3 2021

Oct 29, 2021

SELL
$116.66 - $129.06 $296,666 - $328,199
-2,543 Reduced 0.78%
322,080 $38 Million
Q2 2021

Aug 06, 2021

BUY
$105.79 - $124.53 $12.5 Million - $14.7 Million
117,901 Added 57.03%
324,623 $38 Million
Q1 2021

May 11, 2021

SELL
$108.84 - $128.23 $556,390 - $655,511
-5,112 Reduced 2.41%
206,722 $24.8 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $22.2 Million - $24.2 Million
211,834 New
211,834 $26.4 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.